PMID: 4288480Oct 1, 1966Paper

Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses

The Journal of Experimental Medicine
G GeeringE A Boyse

Abstract

Leukemias can be induced in W/Fu inbred rats by neonatal inoculation of normal thymus cells of C58 mice. These leukemias are not transplantable to C58 mice or to adult W/Fu rats, but they can be kept in passage in W/Fu rats aged 0 to 7 days. Adult W/Fu rats inoculated repeatedly with these isogenic leukemias produce cytotoxic and precipitating antibodies. These antisera are of particular value in the analysis of the antigens of leukemia cells and of leukemia viruses because their mode of preparation precludes the formation of antibody against any normal constituents of the cell. Analysis based on the cytotoxic test indicates the presence of 2 distinct cell surface antigens in leukemias induced by Passage A Gross virus or occurring spontaneously in mice of high-incidence strains. All leukemias and other tissues known to contain G (Gross) leukemia antigen have both determinants, but certain leukemias of low-incidence strains have only 1 of them and so were previously classified G-. Immunoprecipitation with these antisera reveals the presence of a cellular antigen common to G+ cells and absent from G- cells; the same antigen can be demonstrated in ether-treated Gross virus, but not in intact virus. This antigen is present also in ...Continue Reading

References

Jan 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·C B Huggins, T Sugiyama
Apr 1, 1957·Proceedings of the Society for Experimental Biology and Medicine·L GROSS
Oct 1, 1964·Proceedings of the National Academy of Sciences of the United States of America·B STUECKE A BOYSE

❮ Previous
Next ❯

Citations

Oct 1, 1976·Biulleten' eksperimental'noĭ biologii i meditsiny·K V Il'in
Oct 1, 1969·Biulleten' eksperimental'noĭ biologii i meditsiny·E S IevlevaG I Abelev
Jan 1, 1972·Archiv für die gesamte Virusforschung·V M ZhdanovA F Bykovsky
Mar 1, 1981·Immunogenetics·R Hyman, I Trowbridge
Jan 1, 1977·Medical Microbiology and Immunology·J N IhleM G Hanna
Sep 15, 1978·Brain Research·J F Lesley, V A Lennon
Dec 14, 1984·Journal of Immunological Methods·D Gerlier, T Avice
Apr 6, 1988·Journal of Immunological Methods·E CurlingP Morris
Mar 31, 1989·Journal of Immunological Methods·H SchäferR Burger
Nov 8, 1969·Nature·J P LevyJ C Leclerc
Sep 1, 1967·Proceedings of the National Academy of Sciences of the United States of America·R J Huebner
Nov 1, 1969·Proceedings of the National Academy of Sciences of the United States of America·R J Huebner, G J Todaro
Feb 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·G KelloffR Gilden
Mar 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·T AokiH A Wood
Oct 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·A E FreemanR J Huebner
Dec 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·B A TaylorD D Myers
Jul 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·R C NowinskiN H Sarkar
Jan 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·E L KuffN A Wivel
Jul 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·C C TingR B Herberman
Jul 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·P J FischingerW Schäfer
Oct 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·J KeydarY Ben-Shaul
Mar 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·G J TodaroR J Huebner
May 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·T Aoki, G J Todaro
Jun 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·T YoshikiW D Hardy
May 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·P LonaiH S Kaplan
Sep 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·T AokiK C Hsu
Dec 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·P J FischingerD P Bolognesi
Apr 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·K L FieldsP L Stern
Jan 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·R C Mellors, J W Mellors
Dec 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·K KawashimaL J Old
Jun 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·E StockertK Itakura
Aug 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·R S Yalow, L Gross
May 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·R C Mellors, J W Mellors
Oct 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·L B JerabekJ W Mellors
May 1, 1969·The Journal of Experimental Medicine·R C MellorsR J Huebner
Jan 1, 1971·The Journal of Experimental Medicine·R C MellorsK Krawczynski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.